Biotech IPOs have slept through 2023. When will they wake up?


The biotech IPO market has ground to a halt. Experts believe the window may open again in the next year. Here are the signs they're looking for.

Previous Pike District Partnership's new boss charged with improving North Bethesda marketing so future HQ2s not lost
Next Rich Products' 'lift-and-adapt' strategy fuels ongoing global growth at the $5.8B business